Stockscreener 앱 받기
0.3862
4.38%
0.0162
전일 마감가:
$0.37
열려 있는:
$0.39
하루 거래량:
826.59K
Relative Volume:
0.91
시가총액:
$20.39M
수익:
-
순이익/손실:
$-24.08M
주가수익비율:
-0.4505
EPS:
-0.8572
순현금흐름:
$-14.75M
1주 성능:
-17.85%
1개월 성능:
-47.38%
6개월 성능:
-57.84%
1년 성능:
-78.18%
1일 변동 폭
$0.3804
$0.41
1주일 범위
$0.3622
$0.4923
52주 변동 폭
$0.3622
$3.02
Iterum Therapeutics Plc Stock (ITRM) Company Profile
명칭
Iterum Therapeutics Plc
전화
(872) 225-6077
주소
3 DUBLIN LANDINGS, DUBLIN 1
ITRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.3862 | 19.53M | 0 | -24.08M | -14.75M | -0.8572 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-28 | 업그레이드 | Gabelli & Co | Sell → Hold |
| 2021-03-15 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | 다운그레이드 | Gabelli & Co | Buy → Sell |
| 2019-12-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | 개시 | H.C. Wainwright | Buy |
모두보기
Iterum Therapeutics Plc 주식(ITRM)의 최신 뉴스
Is Iterum Therapeutics plc stock attractive after correctionPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Why retail investors favor Iterum Therapeutics plc stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Can Iterum Therapeutics plc stock maintain operating marginsJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Iterum Therapeutics director Dunne buys $2,191 in shares By Investing.com - Investing.com Nigeria
Dir Dunne Buys 6,000 ($2.2K) Of Iterum Therapeutics PLC [ITRM] - TradingView
[Form 4] Iterum Therapeutics plc Insider Trading Activity - Stock Titan
Can Iterum Therapeutics plc stock resist market sell offs2025 Big Picture & Fast Gain Swing Alerts - newser.com
Why Iterum Therapeutics plc stock appeals to analysts2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Combining machine learning predictions for Iterum Therapeutics plc2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-11-19 01:58:59 - newser.com
Is Iterum Therapeutics plc stock attractive for long term wealth buildingQuarterly Market Review & Risk Managed Investment Strategies - newser.com
Using portfolio simulators with Iterum Therapeutics plc includedMarket Trend Report & Reliable Entry Point Alerts - newser.com
There is no way Iterum Therapeutics Plc (ITRM) can keep these numbers up - Setenews
Visualizing Iterum Therapeutics plc stock with heatmaps2025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Iterum Therapeutics plc stock split attract more investorsCPI Data & Reliable Breakout Forecasts - newser.com
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2025 Earnings Call Transcript - Insider Monkey
Iterum Therapeutics PLC (ITRM) Stock Price, Trades & News - GuruFocus
Iterum projects $5M–$15M in 2026 ORLYNVAH sales while advancing streamlined commercialization and payer access - MSN
Earnings call transcript: Iterum Therapeutics misses Q3 2025 EPS targets By Investing.com - Investing.com South Africa
Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ... By GuruFocus - Investing.com Canada
Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ... - Yahoo Finance
Earnings call transcript: Iterum Therapeutics misses Q3 2025 EPS targets - Investing.com
Iterum Therapeutics (ITRM) Earnings Transcript - The Motley Fool
Iterum Therapeutics plc (ITRM) Q3 FY2025 earnings call transcript - Yahoo Finance
Iterum Therapeutics (ITRM) Reports Revenue Surge with ORLYNVAH L - GuruFocus
Iterum Therapeutics Plc (ITRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):